Entomologists offer new hope for controlling malariaMarch 07, 2001Entomologists are bringing new hope of preventing malaria in tropical villages. Research published in the new issue of the Royal Entomological Society journal Medical & Veterinary Entomology could significantly improve the effectiveness of insecticide-treated mosquito nets. One paper (Guillet et al, Medical & Veterinary Entomology, 15(1), pp. 105-112), describes the development of “two-in-one” mosquito nets impregnated with two different classes of insecticide - pyrethroids and carbamates. Not only are “two-in-one” nets more effective at controlling the malaria-carrying Anopheles mosquito, but they are also better at controlling the nuisance mosquito Culex. The latter is important in encouraging wider uptake of insecticide-treated nets. The use of a combination of two insecticides should also help to reduce the spread of pyrethroid resistance among Anopheles mosquitoes, which is becoming a problem in some areas of Africa, Central America, Turkey and the Middle East. According to the authors Dr Pierre Guillet of the World Health Organization and his co-workers at the Institut Pierre Richet in the Ivory Coast: “Nets could be more effective if treated on the upper part with a carbamate and with a pyrethroid on the lower part . . . This new approach is based on the observed behaviour of mosquitoes flying around a bednet and occasionally settling on it. From sleepers under the bednet, heat and carbon dioxide emanate and move upwards thermally within the net, which acts like a chimney. Consequently, foraging females tend to begin exploring nets on the upper part, proceeding downwards looking for any bloodmeal opportunity.” Dr Guillet will also be speaking on the subject at a major meeting on insecticide-treated mosquito nets organised by the “Roll Back Malaria” movement at the World Health Organization headquarters in Geneva on 12-13 March 2001. In another paper in this month’s Medical & Veterinary Entomology, Professor Janet Hemingway and her colleagues at Cardiff University describe an important new test for measuring pyrethroid concentrations on mosquito nets (Enayati et al, Medical & Veterinary Entomology, 15(1), pp. 58-63). Based on a simple iodine volumetric titration which can be read by eye, the new assay is a major advance on other tests which are too complex or too expensive to be used in the field in malaria zones. According to Professor Hemingway: “Our method could easily be used in the field to quantify pyrethroid insecticides from impregnated bednets. It should be relatively easy to adapt this method to produce a test kit for residue quantification in the field.” A simple and cost-effective means of monitoring the amount of pyrethroid is a key part of anti-malaria strategies based on mosquito nets. “To achieve effective mosquito control and manage insecticide resistance development, the amount of pyrethroid insecticide on treated bednets should be monitored regularly to determine their failure points under field conditions and quantify the reimpregnation rates achieved in community-based bednet programmes,” says Professor Hemingway. In Africa alone over 2 million people die every year from malaria, most of them young children. Malaria is also a serious risk for tourists in the tropics. - ends - Royal Entomological Society (RES) |
|||||||||||||||||||||
| Related Malaria Current Events and Malaria News Articles Measuring and modeling blood flow in malaria When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells. On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. Small nanoparticles bring big improvement to medical imaging If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging. Prioritizing low-cost, simple health measures would save 2.5 million child lives a year Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes. Drug industry, nonprofits join forces to fight world's neglected diseases Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. DNA barcodes: Creative new uses span health, fraud, smuggling, history, more The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others. PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa. More Malaria Current Events and Malaria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||